PRA Health Sciences, Inc.
PRAHDelisted- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001613859
PRA Health Sciences, Inc. was delisted in 2021; its insiders filed their last Form 4 on Jul 1, 2021; 317 institutions reported holding it in 13F filings for Q2 2021, worth $10.1B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 317
- Q2 2021, −6 vs. previous quarter
- 13F value
- $10.1B
- Reported value at the end of Q2 2021
- Superinvestors holding
- 0
- At the end of Q2 2021
Superinvestors holding PRAH, Q2 2021
No superinvestor reported holding PRAH at the end of Q2 2021.
Latest insider trades
Open-market purchases and sales by PRA Health Sciences, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by PRA Health Sciences, Inc. insiders are on file.
Top 10 13F holders, Q2 2021
The largest institutional positions in PRA Health Sciences, Inc. at the end of Q2 2021; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 4,358,664 | $720.1M | 0.02% | −2,268,786−34.2% | Reduced |
| Millennium Management LLC | 3,730,627 | $616.3M | 0.79% | +3,476,898+1,370.3% | Added |
| Massachusetts Financial Services Co | 3,242,859 | $535.8M | 0.16% | −2,412,154−42.7% | Reduced |
| HBK Investments L P | 3,176,454 | $524.8M | 5.03% | +3,176,454 | New |
| Capital Research Global Investors | 2,298,597 | $379.8M | 0.09% | −1,127,045−32.9% | Reduced |
| Wellington Management Group LLP | 2,223,324 | $367.3M | 0.06% | −17,848−0.8% | Reduced |
| UBS Oconnor LLC | 1,781,846 | $294.4M | 2.63% | +1,531,846+612.7% | Added |
| Vanguard Group Inc | 1,775,342 | $293.3M | 0.01% | −4,194,199−70.3% | Reduced |
| Alpine Associates Management Inc. | 1,500,254 | $247.9M | 6.80% | +235,434+18.6% | Added |
| Glazer Capital, LLC | 1,470,617 | $243.0M | 3.77% | +1,470,617 | New |